Astellas Pharma (Astellas Pharma) Other Long Term Assets : $1,314 Mil (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Astellas Pharma Other Long Term Assets?

Astellas Pharma's other long-term assets for the quarter that ended in Dec. 2023 was $1,314 Mil.

Astellas Pharma's quarterly other long-term assets declined from Jun. 2023 ($1,723 Mil) to Sep. 2023 ($1,308 Mil) but then increased from Sep. 2023 ($1,308 Mil) to Dec. 2023 ($1,314 Mil).

Astellas Pharma's annual other long-term assets declined from Mar. 2021 ($1,849 Mil) to Mar. 2022 ($1,801 Mil) and declined from Mar. 2022 ($1,801 Mil) to Mar. 2023 ($1,715 Mil).

Astellas Pharma Other Long Term Assets Historical Data

The historical data trend for Astellas Pharma's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astellas Pharma Other Long Term Assets Chart

Astellas Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Long Term Assets

Get a 7-Day Free Trial

1,902.35

1,634.94

1,848.95

1,800.82

1,714.73

Astellas Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial															1,716.96	1,714.73	1,723.38	1,307.70	1,314.34

Astellas Pharma Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Astellas Pharma (Astellas Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Astellas Pharma Inc (OTCPK:ALPMY) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

ALPMF:USA 4503:Mexico 4503:Japan YPHA:Germany

Address

2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8411

Website

http://www.astellas.com

Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Royalty income makes up a small percentage of Astellas' overall sales. Its largest therapeutic area by sales composition is oncology, followed by urology and transplantation. The company uses mergers and acquisitions as part of its long-term growth strategy. Astellas enters into strategic partnerships and licensing agreements to strengthen its commercialization platforms.